Troponin I as a Biomarker for Early Detection of Acute Myocardial Infarction

Curr Probl Cardiol. 2023 May;48(5):101067. doi: 10.1016/j.cpcardiol.2021.101067. Epub 2021 Nov 23.

Abstract

Acute myocardial infarction (AMI) as the main cause of death among cardiovascular diseases is defined as a deficiency of oxygen that generates irreversible tissue necrosis in the heart muscle. For diagnostic measurements, the evaluation of cardiac markers concentration like cardiac triponin I (cTnI) in plasma or saliva thought the use of biosensors has become one of the most commonly applied strategies for prognosis of AMI. Inside this diagnostic devices, electrochemical (ECL) ones have been highly encourage to improve sensing capabilities by using different materials and configurations. In this review, the authors presents a summary of studies that involves cTnI detection using ECL biosensors modified with nanomaterials and related mechanisms.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Humans
  • Myocardial Infarction* / diagnosis
  • Myocardium
  • Prognosis
  • Troponin I*

Substances

  • Troponin I
  • Biomarkers